Clicky

Bioleaders Corporation(142760)

Description: Bioleaders Corporation engages in the medicine and consumer business in South Korea. The company offers P53, a target anti-cancer drug. Its pipeline products include BLS-H01, which is in phase 3 clinical trial for the treatment vaccine of cervical cancer; BLC-H03, an H. vaccine adjuvant that is in preclinical stage; BLS-M07 that has completed phase 2b clinical trial for the treatment of cervical cancer; and BLS-M22 for the treatment of Duchenne muscular dystrophy. The company also provides health functional foods and raw materials, and cosmetical raw materials. Bioleaders Corporation was founded in 1999 and is headquartered in Yongin-si, South Korea.


Keywords: Vaccines Muscular Dystrophy Cervical Cancer Papillomavirus P53 Treatment Of Cervical Cancer

Home Page: www.bioleaders.co.kr

A-7, 767, Sinsu-ro
Yongin-Si,
South Korea
Phone: 82 3 1280 9650


Officers

Name Title
Mr. Moon-Hee Sung Chief Exec. Officer
Mr. Hyun-Jae Sung Chief Financial Officer and Sr. Managing Director
Mr. Chul-Joong Kim Chief Technology Officer

Exchange: KQ

Country: KR : Korea (Republic of)

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 1.7354
IPO Date:
Fiscal Year End: December
Full Time Employees: 53
Back to stocks